ROIV logo

Roivant Sciences Ltd. (ROIV)

Profile

Full Name

Roivant Sciences Ltd.

Ticker

NASDAQ: ROIV

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United Kingdom

IPO

December 8, 2020

Indexes

Not included

Website

https://roivant.com

Employees

750

Key Details

Price

$11.93(-0.08%)

Market cap

$8.15B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$29.05M(-11.19% YoY)

Annual EPS

-$0.24(-104.59% YoY)

PE ratio

-

Next earnings date

Nov 10, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $11.93
    ROIV price is $11.93

    30-Day Relative Volume

    0.96
    ROIV 30-day relative volume is 0.96

    Price Performance

    Price Most recent change

    -0.08%
    ROIV price was down -0.08% on Aug 29, 2025

    Price YTD change

    +0.85%
    ROIV price is up +0.85% since January 1st

    Price 1-year change

    -0.75%
    ROIV price is down -0.75% year-on-year

    Price 3-year change

    +231.39%
    ROIV price is up +231.39% over the past 3 years

    Price Range

    Price All-time high

    $16.76
    ROIV price is currently -28.82% below its historical high of $16.76

    Price 3-year low

    $2.87
    ROIV price is currently +315.68% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $8.15B
    ROIV market capitalization is $8.15 billion

    Market cap 3-year change

    +221.62%
    ROIV market capitalization is up +221.62% over the past 3 years

    Market cap All-time high

    $10.28B
    ROIV market capitalization is currently -20.74% below its historical high of $10.28 billion

    Market cap sector rank

    90.96%
    ROIV market capitalization is higher than 90.96% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -7.66%
    ROIV shares outstanding is down -7.66% year-on-year

    Shares Outstanding 3-Year Change

    -2.95%
    ROIV shares outstanding is down -2.95% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.82
    ROIV beta is 0.82

    200-day SMA

    $11.17
    ROIV price is currently +6.80% above its 200-day simple moving average

    50-day SMA

    $11.50
    ROIV price is currently +3.73% above its 50-day simple moving average

    RSI

    57.08
    ROIV 14-day relative strength index is 57.08

    Volume

    0.96
    ROIV 30-day relative volume is 0.96

    ATR

    $0.28
    ROIV average true range is $0.28

    10-day Historical Volatility

    18.40%
    ROIV 10-day historical volatility is 18.40%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $29.05M
    ROIV annual revenue is $29.05 million

    Revenue Analysts estimate

    $23.37M
    ROIV annual revenue is currently +24.29% higher than the consensus analysts' forecast

    Revenue 1-year change

    -11.19%
    ROIV annual revenue is down -11.19% year-on-year

    Revenue Sector rank

    56.13%
    ROIV annual revenue is higher than 56.13% of companies in Healthcare sector

    EPS

    EPS

    -$0.24
    ROIV annual earnings per share is -$0.24

    EPS Analysts estimate

    -$1.03
    ROIV annual earnings per share is currently -76.77% lower than the consensus analysts' forecast

    EPS 1-year change

    -104.59%
    ROIV annual earnings per share is down -104.59% year-on-year

    EPS Sector rank

    69.93%
    ROIV annual earnings per share is higher than 69.93% of companies in Healthcare sector

    Profit

    Gross profit

    $20.81M
    ROIV annual gross profit is $20.81 million

    Gross margin

    71.63%
    ROIV annual gross profit margin is 71.63%

    Operating profit

    -$1.11B
    ROIV annual operating income is -$1.11 billion

    Operating margin

    -3861.65%
    ROIV annual operating profit margin is -3861.65%

    Net income

    -$729.76M
    ROIV annual net profit is -$729.76 million

    Net margin

    -2511.84%
    ROIV annual net profit margin is -2511.84%

    Expenses

    Total expenses

    $574.06M
    ROIV annual total expenses is $574.06 million

    Operating expenses

    $1.13B
    ROIV annual total operating expenses is $1.13 billion

    Cost of goods sold

    $8.24M
    ROIV annual cost of goods sold is $8.24 million

    Selling, general & administrative expenses

    $0.00
    ROIV annual SGA is $0.00

    Depreciation and amortization

    $7.33M
    ROIV annual depreciation & amortization is $7.33 million

    Interest expense

    $0.00
    ROIV annual interest expense is $0.00

    Income tax

    $48.17M
    ROIV annual income tax is $48.17 million

    EBIT & EBITDA

    EBIT

    -$1.11B
    ROIV annual earnings before interest & taxes is -$1.11 billion

    EBITDA

    -$1.11B
    ROIV annual EBITDA is -$1.11 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $5.44B
    ROIV annual total assets is $5.44 billion

    Non current assets

    $436.88M
    ROIV annual long term assets is $436.88 million

    Current assets

    $5.00B
    ROIV annual total current assets is $5.00 billion

    Cash and cash equivalents

    $4.89B
    ROIV annual cash & cash equivalents is $4.89 billion

    Accounts receivable

    -
    ROIV annual accounts receivable value is unknown

    Inventory

    $0.00
    ROIV annual inventory is $0.00

    Liabilities

    Total liabilities

    $249.74M
    ROIV annual total liabilities is $249.74 million

    Long term liabilities

    $100.33M
    ROIV annual total long term liabilities is $100.33 million

    Current liabilities

    $149.41M
    ROIV annual total current liabilities is $149.41 million

    Accounts payable

    $23.69M
    ROIV annual accounts payable is $23.69 million

    Debt

    Total debt

    $100.17M
    ROIV annual total debt is $100.17 million

    Total debt 1-year change

    +85.55%
    ROIV annual total debt is up +85.55% year-on-year

    Long term debt

    $90.33M
    ROIV annual long term debt is $90.33 million

    Short term debt

    $9.84M
    ROIV annual short term debt is $9.84 million

    Equity & Capital

    Shareholders equity

    $4.69B
    ROIV annual stockholders equity is $4.69 billion

    Book value

    $4.69B
    ROIV annual book value is $4.69 billion

    Retained earnings

    $116.06M
    ROIV annual retained earnings is $116.06 million

    Working capital

    $4.85B
    ROIV annual working capital is $4.85 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$839.45M
    ROIV annual cash flow from operations is -$839.45 million

    Cash from operations 1-year change

    -9.69%
    ROIV annual cash flow from operations is down -9.69% year-on-year

    Cash from investing

    -$1.77B
    ROIV annual cash flow from investing activities is -$1.77 billion

    Cash from investing 1-year change

    -133.94%
    ROIV annual cash flow from investing activities is down -133.94% year-on-year

    Cash from financing

    -$1.22B
    ROIV annual cash flow from financing activities is -$1.22 billion

    Cash from financing 1-year change

    -390.87%
    ROIV annual cash flow from financing activities is down -390.87% year-on-year

    CAPEX

    CAPEX

    $4.60M
    ROIV annual capital expenditures is $4.60 million

    CAPEX 1-year change

    +232.78%
    ROIV annual capital expenditures is up +232.78% year-on-year

    Free Cash Flow

    Free cash flow

    -$844.05M
    ROIV annual free cash flow is -$844.05 million

    Free cash flow 1-year change

    -10.1%
    ROIV annual free cash flow is down -10.1% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    71.63%
    ROIV annual gross profit margin is 71.63%

    Operating margin

    -3861.65%
    ROIV annual operating profit margin is -3861.65%

    Net margin

    -2511.84%
    ROIV annual net profit margin is -2511.84%

    ROA & ROE

    ROA

    -11.53%
    ROIV annual return on assets is -11.53%

    ROE

    -12.54%
    ROIV annual return on equity is -12.54%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ROIV price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ROIV price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.87
    ROIV price to book ratio is 1.87

    PB ratio Sector rank

    52.2%
    ROIV price to book ratio is higher than 52.2% of companies in Healthcare sector

    PS Ratio

    PS ratio

    350.66
    ROIV price to sales ratio is 350.66

    PS ratio Sector rank

    95.21%
    ROIV price to sales ratio is higher than 95.21% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $3.74B
    ROIV enterprise value is $3.74 billion

    Enterprise value Sector rank

    86.49%
    ROIV enterprise value is higher than 86.49% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -3.16
    ROIV EV/EBITDA is -3.16

    EV/EBITDA Sector rank

    28.74%
    ROIV EV/EBITDA is higher than 28.74% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    33.47
    ROIV annual current ratio is 33.47

    Quick ratio

    33.47
    ROIV annual quick ratio is 33.47

    Leverage

    Debt to equity

    0.02
    ROIV annual debt to equity ratio is 0.02

    Interest coverage ratio

    -
    ROIV annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    5
    ROIV piotroski f-score is 5

    Altman Z-Score

    20.00
    ROIV altman z-score is 20.00

    Analyst ratings

    Recent major analysts updates

    Jun 18, 25 HC Wainwright & Co.
    Buy
    May 28, 25 HC Wainwright & Co.
    Buy
    Apr 21, 25 HC Wainwright & Co.
    Buy
    Feb 11, 25 HC Wainwright & Co.
    Buy
    Nov 13, 24 HC Wainwright & Co.
    Buy
    Sep 19, 24 HC Wainwright & Co.
    Buy
    Sep 19, 24 Cantor Fitzgerald
    Overweight
    Sep 11, 24 HC Wainwright & Co.
    Buy
    Sep 11, 24 B of A Securities
    Neutral
    Sep 9, 24 Cantor Fitzgerald
    Overweight

    Institutional Ownership

    Screeners with ROIV included

    Mid cap stocks
    UK stocks
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    Best performing stocks last 3 years
    High Altman Z score stocks
    • What is the ticker symbol for Roivant Sciences Ltd.?
    • Does Roivant Sciences Ltd. pay dividends?
    • What sector is Roivant Sciences Ltd. in?
    • What industry is Roivant Sciences Ltd. in?
    • What country is Roivant Sciences Ltd. based in?
    • When did Roivant Sciences Ltd. go public?
    • Is Roivant Sciences Ltd. in the S&P 500?
    • Is Roivant Sciences Ltd. in the NASDAQ 100?
    • Is Roivant Sciences Ltd. in the Dow Jones?
    • When was Roivant Sciences Ltd.'s last earnings report?
    • When does Roivant Sciences Ltd. report earnings?

    What is the ticker symbol for Roivant Sciences Ltd.?

    The ticker symbol for Roivant Sciences Ltd. is NASDAQ:ROIV

    Does Roivant Sciences Ltd. pay dividends?

    No, Roivant Sciences Ltd. does not pay dividends

    What sector is Roivant Sciences Ltd. in?

    Roivant Sciences Ltd. is in the Healthcare sector

    What industry is Roivant Sciences Ltd. in?

    Roivant Sciences Ltd. is in the Biotechnology industry

    What country is Roivant Sciences Ltd. based in?

    Roivant Sciences Ltd. is headquartered in United Kingdom

    When did Roivant Sciences Ltd. go public?

    Roivant Sciences Ltd.'s initial public offering (IPO) was on December 8, 2020

    Is Roivant Sciences Ltd. in the S&P 500?

    No, Roivant Sciences Ltd. is not included in the S&P 500 index

    Is Roivant Sciences Ltd. in the NASDAQ 100?

    No, Roivant Sciences Ltd. is not included in the NASDAQ 100 index

    Is Roivant Sciences Ltd. in the Dow Jones?

    No, Roivant Sciences Ltd. is not included in the Dow Jones index

    When was Roivant Sciences Ltd.'s last earnings report?

    Roivant Sciences Ltd.'s most recent earnings report was on August 11, 2025

    When does Roivant Sciences Ltd. report earnings?

    The next expected earnings date for Roivant Sciences Ltd. is November 10, 2025
    On this page